Morphic Holding Inc (NASDAQ:MORF)

31.69
Delayed Data
As of 3:58pm ET
 +0.50 / +1.60%
Today’s Change
9.90
Today|||52-Week Range
36.65
-5.54%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$970.5M

Company Description

Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.

Contact Information

Morphic Holding, Inc.
35 Gatehouse Drive A2
Waltham Massachusetts 02451
P:(781) 996-0955
Investor Relations:
--

Employees

Shareholders

Individual stakeholders26.94%
Other institutional24.64%
Mutual fund holders19.08%

Top Executives

Praveen P. TipirneniPresident, Chief Executive Officer & Director
Marc SchegerinChief Operating & Financial Officer
Bruce N. RogersChief Scientific Officer
Peter G. LindeChief Medical Officer
Robert E. FarrellTreasurer & Chief Accounting Officer